Michail Vikelis

20PUBLICATIONS
16CO-AUTHORS
Medical physicsSensory systemsRegenerative medicine (incl. stem cells)PharmacogenomicsPain
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Oct 22, 2026
Effectiveness of eptinezumab 300 mg dose escalation in partial responders to 100 mg among patients with difficult-to-treat migraine: A prospective, real-world study by the GRASP study group.

|Jun 25, 2026
Botulinumtoxin Type-A (BoNTA) in the Management of Refractory Trigeminal Neuralgia: An Expert-Opinion, Practice-Oriented Narrative Review on Behalf of the GRASP Study Group.

|Jun 04, 2026
Achieving International Headache Society-aspired optimal migraine control in fremanezumab-treated patients: A post-hoc analysis of a real-world, prospective study from the GRASP study group.

|Apr 27, 2026
Comparing the Efficacy and Safety of Anti-CGRP Monoclonal Antibodies Versus Topiramate for Migraine Prophylaxis: Six-Month, Real-World, Intention-to-Treat Retrospective Evidence from the GRASP Study Group.

|Dec 30, 2025
Testing the Efficacy of Eptinezumab 100 mg in the Early Prevention of Chronic Migraine over Weeks 1 to 4: Prospective Real-World Data from the GRASP Study Group.

Andreas A Argyriou, Emmanouil V Dermitzakis, Maria Chondrogianni

|Nov 26, 2025
OnabotulinumtoxinA to Prevent Chronic Migraine with Comorbid Bruxism: Real-World Data from the GRASP Study Group.

Andreas A Argyriou, Emmanouil V Dermitzakis, Maria Chondrogianni

Pageof 4

Frequent Collaborators

19 joint publications

Emmanouil V Dermitzakis

19 joint publications

Andreas A Argyriou

9 joint publications

Dimitrios Rikos

4 joint publications

Georgia Xiromerisiou